Investigation of the corticotropin-releasing hormone-proopiomelanocortin axis in various skin tumours

British Journal of Dermatology

Volumn 155, Issue 5, 2006, Pages 910-915

  Kim, M H ^a   Cho, D ^b   Kim, H J ^a   Chong, S J ^a   Lee, K H ^a   Yu, D S ^a   Park, C J ^a   Lee, J Y ^a   Cho, B K ^a   Park, H J ^a  

^a The Catholic University of Korea   (South Korea)

^b Sookmyung Women's University   (South Korea)

Author keywords

melanocyte stimulating hormone; Adrenocorticotropic hormone; Corticotropin releasing hormone; Corticotropin releasing hormone proopiomelanocortin axis; Skin tumour

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; PROOPIOMELANOCORTIN;

ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATINOCYTE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MELANOMA; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; STRESS; TUMOR CELL LINE;

ADRENOCORTICOTROPIC HORMONE; ALPHA-MSH; CORTICOTROPIN-RELEASING HORMONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MELANOMA; NEOPLASM PROTEINS; PRO-OPIOMELANOCORTIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 33749857509     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07442.x     Document Type: Article

References (28)

1. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338:171-9.
2. Hasegawa H, Saiki I. Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn J Cancer Res 2002; 93:729-35.
3. Mains RE, Eipper BA, Ling N. Common precursor to corticotropins and endorphins. Proc Natl Acad Sci USA 1977; 74:3014-18.
4. Slominski A, Mihm MC. Potential mechanism of skin response to stress. Int J Dermatol 1996; 35:849-51.
5. Slominski A, Wortsman J, Luger T et al. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000; 80:979-1020.
6. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev 2000; 21:457-87.
7. Slominski AT, Botchkarev V, Choudhry M et al. Cutaneous expression of CRH and CRH-R. Is there a 'skin stress response system'? Ann NY Acad Sci 1999; 885:287-311.
8. Slominski A, Zbytek B, Szczesniewski A et al. CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab 2005; 288:E701-6.
9. Slominski A, Wortsman J, Pisarchik A et al. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 2001; 15:1678-93.
10. Slominski A, Roloff B, Curry J et al. The skin produces urocortin. J Clin Endocrinol Metab 2000; 85:815-23.
11. Slominski A, Pisarchik A, Tobin DJ et al. Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 2004; 145:941-50.
12. Slominski A, Zbytek B, Pisarchik A et al. CRH functions as a growth factor/cytokine in the skin. J Cell Physiol 2006; 206:780-91.
13. Slominski A, Wortsman J, Mazurkiewicz JE et al. Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 1993; 122:658-66.
14. Slominski A, Heasley D, Mazurkiewicz JE et al. Expression of proopiomelanocortin (POMC)-derived melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) peptides in skin of basal cell carcinoma patients. Hum Pathol 1999; 30:208-15.
15. Slominski A. Identification of beta-endorphin, alpha-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC. Exp Dermatol 1998; 7:213-16.
16. Sato H, Nagashima Y, Chrousos GP et al. The expression of corticotropin-releasing hormone in melanoma. Pigment Cell Res 2002; 15:98-103.
17. Vamvakopoulos NC, Chrousos GP. Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocr Rev 1994; 15:409-20.
18. Arbiser JL, Karalis K, Viswanathan A et al. Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin. J Invest Dermatol 1999; 113:838-42.
19. Yang EV, Bane CM, MacCallum RC et al. Stress-related modulation of matrix metalloproteinase expression. J Neuroimmunol 2002; 133:144-50.
20. Hofmann UB, Westphal JR, van Muijen GN, Ruiter DJ. Matrix metalloproteinases in human melanoma. J Invest Dermatol 2000; 115:337-44.
21. Fundyler O, Khanna M, Smoller BR. Metalloproteinase-2 expression correlates with aggressiveness of cutaneous squamous cell carcinomas. Mod Pathol 2004; 17:496-502.
22. Kerkela E, Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 2003; 12:109-25.
23. Dumas V, Kanitakis J, Charvat S et al. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas. Anticancer Res 1999; 19:2929-38.
24. Slominski A, Pawelek J. Animals under the sun: effects of ultraviolet radiation on mammalian skin. Clin Dermatol 1998; 16:503-15.
25. Scholzen TE, Brzoska T, Kalden DH et al. Effect of ultraviolet light on the release of neuropeptides and neuroendocrine hormone in the skin: mediators of photodermatitis and cutaneous inflammation. J Invest Dermatol Symp Proc 1999; 4:55-9.
26. Freeman SE, Hacham H, Gange RW et al. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci USA 1989; 86:5605-9.
27. Ziegler A, Leffell DJ, Kunala S et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 1993; 90:4216-20.
28. Iordanov MS, Choi RJ, Ryabinina OP et al. The UV (ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor. Mol Cell Biol 2002; 22:5380-94.